VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 225 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $322 | -70.8% | 34,382 | -23.6% | 0.00% | -100.0% |
Q2 2023 | $1,104 | +24.5% | 45,000 | +18.0% | 0.00% | 0.0% |
Q1 2023 | $887 | -54.3% | 38,135 | -50.3% | 0.00% | -66.7% |
Q4 2022 | $1,942 | -99.9% | 76,720 | +2.4% | 0.00% | +50.0% |
Q3 2022 | $1,445,000 | -28.7% | 74,941 | -5.8% | 0.00% | -33.3% |
Q2 2022 | $2,027,000 | +82.0% | 79,595 | +83.8% | 0.00% | +200.0% |
Q1 2022 | $1,114,000 | -38.6% | 43,317 | +0.1% | 0.00% | -50.0% |
Q4 2021 | $1,813,000 | -4.1% | 43,290 | -0.3% | 0.00% | 0.0% |
Q3 2021 | $1,890,000 | -23.1% | 43,422 | -16.4% | 0.00% | -33.3% |
Q2 2021 | $2,457,000 | -1.2% | 51,958 | +7.1% | 0.00% | 0.0% |
Q1 2021 | $2,487,000 | +91.5% | 48,500 | 0.0% | 0.00% | +200.0% |
Q4 2020 | $1,299,000 | -22.0% | 48,500 | 0.0% | 0.00% | -50.0% |
Q3 2020 | $1,665,000 | -4.4% | 48,500 | +14.1% | 0.00% | 0.0% |
Q2 2020 | $1,741,000 | +519.6% | 42,500 | +418.3% | 0.00% | – |
Q1 2020 | $281,000 | +172.8% | 8,200 | 0.0% | 0.00% | – |
Q4 2019 | $103,000 | – | 8,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |